UC Irvine Health Affairs
Alan Goldin, MD, PhD, is serving as interim vice chancellor of UC Irvine's Susan and Henry Samueli College of Health Sciences

Dr. Alan L. Goldin has been named interim vice chancellor of the Susan and Henry Samueli College of Health Sciences.

Read More »

Alana LeBrón, UC Irvine assistant professor of Chicano/Latino Studies and Public Health

A new study led by UC Irvine found that self-reported incidents of racial discrimination among blacks and Latinos were linked to higher blood pressure levels, putting them at risk for heart disease.

Read More »

Robert Spitale, assistant professor of pharmaceutical sciences, left, and John Chaput, professor of pharmaceutical sciences, chemistry, and molecular biology & biochemistry, win $1-million grant from the W.M. Keck Foundation to develop new RNA tools.

Pharmaceutical sciences professors land $1-million Keck Foundation grant to develop RNA tools

Read More »

UC Irvine doctoral candidates Shirley Zhang, left, and Linan Liu of the UC Irvine Department of Pharmaceutical Sciences

Stem-cell therapy devised by cancer researcher Weian Zhao and his team in the Department of Pharmaceutical Science attacks cancer by targeting unique tissue stiffness.

Read More »

Strategic Planning Initiative

UC Irvine Health Sciences

Powered by discovery and innovation, UC Irvine Health Sciences will advance individual and population health.

We do this through excellence in research and education within the Susan and Henry Samueli College of Health Sciences (COHS), which includes:

We also do this by delivering exceptional patient care through UC Irvine Health, led by UC Irvine Medical Center, the region's only academic medical center.

Whether through basic, translational or clinical research, new teaching approaches and the establishment of new and best clinical practices, our ability to innovate across these health-related disciplines is the engine that powers our success.

Learn more about UC Irvine Health Sciences ›